Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy

Objective: To investigate the potential mechanisms underlying the protective effects of recombinant human erythropoietin (rhEPO) and carbamylated EPO (CEPO) against myocardial cell apoptosis in epilepsy. Methods: Rats were given an intra-amygdala injection of kainic acid to induce epilepsy. Groups o...

Full description

Bibliographic Details
Main Authors: Bao-Xin Ma, MD, Jie Li, MD, Hua Li, MD, Sui-Sheng Wu, MD
Format: Article
Language:English
Published: Elsevier 2015-12-01
Series:Current Therapeutic Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X15000090
_version_ 1818151488442073088
author Bao-Xin Ma, MD
Jie Li, MD
Hua Li, MD
Sui-Sheng Wu, MD
author_facet Bao-Xin Ma, MD
Jie Li, MD
Hua Li, MD
Sui-Sheng Wu, MD
author_sort Bao-Xin Ma, MD
collection DOAJ
description Objective: To investigate the potential mechanisms underlying the protective effects of recombinant human erythropoietin (rhEPO) and carbamylated EPO (CEPO) against myocardial cell apoptosis in epilepsy. Methods: Rats were given an intra-amygdala injection of kainic acid to induce epilepsy. Groups of rats were treated with rhEPO or CEPO before induction of epilepsy, whereas additional rats were given a caudal vein injection of AG490, a selective inhibitor of Janus kinase 2 (JAK2). At different time points after seizure onset, electroencephalogram changes were recorded, and myocardium samples were taken for the detection of myocardial cell apoptosis and expression of JAK2, signal transducer and activator of transcription 5 (STAT5), caspase-3, and bcl-xl mRNAs and proteins. Results: Induction of epilepsy significantly enhanced myocardial cell apoptosis and upregulated the expression of caspase-3 and bcl-xl proteins and JAK2 and STAT5a at both the mRNA and protein levels. Pretreatment with either rhEPO or CEPO reduced the number of apoptotic cells, upregulated bcl-xl expression, and downregulated caspase-3 expression in the myocardium of epileptic rats. Both myocardial JAK2 and STAT5a mRNAs, as well as phosphorylated species of JAK2 and STAT5a, were upregulated in epileptic rats in response to rhEPO—but not to CEPO—pretreatment. AG490 treatment increased apoptosis, upregulated caspase-3 protein expression, and downregulated bcl-xl protein expression in the myocardium of epileptic rats. Conclusions: These results indicate that myocardial cell apoptosis may contribute to myocardial injury in epilepsy. EPO protects myocardial cells from apoptosis via the JAK2/STAT5 pathway in rats with experimental epilepsy, whereas CEPO exerts antiapoptotic activity perhaps via a pathway independent of JAK2/STAT5 signaling.
first_indexed 2024-12-11T13:39:37Z
format Article
id doaj.art-729c94c6a271458aa9c02b4b396a5771
institution Directory Open Access Journal
issn 0011-393X
1879-0313
language English
last_indexed 2024-12-11T13:39:37Z
publishDate 2015-12-01
publisher Elsevier
record_format Article
series Current Therapeutic Research
spelling doaj.art-729c94c6a271458aa9c02b4b396a57712022-12-22T01:04:50ZengElsevierCurrent Therapeutic Research0011-393X1879-03132015-12-0177C909810.1016/j.curtheres.2015.07.001Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with EpilepsyBao-Xin Ma, MD0Jie Li, MD1Hua Li, MD2Sui-Sheng Wu, MD3Department of Cardiology, Affiliated Hospital of Binzhou Medical University, Binzhou, ChinaDepartment of Geriatrics, First Hospital of Jilin University, Changchun, ChinaDepartment of Cardiology, Affiliated Hospital of Binzhou Medical University, Binzhou, ChinaDepartment of Geriatrics, First Hospital of Jilin University, Changchun, ChinaObjective: To investigate the potential mechanisms underlying the protective effects of recombinant human erythropoietin (rhEPO) and carbamylated EPO (CEPO) against myocardial cell apoptosis in epilepsy. Methods: Rats were given an intra-amygdala injection of kainic acid to induce epilepsy. Groups of rats were treated with rhEPO or CEPO before induction of epilepsy, whereas additional rats were given a caudal vein injection of AG490, a selective inhibitor of Janus kinase 2 (JAK2). At different time points after seizure onset, electroencephalogram changes were recorded, and myocardium samples were taken for the detection of myocardial cell apoptosis and expression of JAK2, signal transducer and activator of transcription 5 (STAT5), caspase-3, and bcl-xl mRNAs and proteins. Results: Induction of epilepsy significantly enhanced myocardial cell apoptosis and upregulated the expression of caspase-3 and bcl-xl proteins and JAK2 and STAT5a at both the mRNA and protein levels. Pretreatment with either rhEPO or CEPO reduced the number of apoptotic cells, upregulated bcl-xl expression, and downregulated caspase-3 expression in the myocardium of epileptic rats. Both myocardial JAK2 and STAT5a mRNAs, as well as phosphorylated species of JAK2 and STAT5a, were upregulated in epileptic rats in response to rhEPO—but not to CEPO—pretreatment. AG490 treatment increased apoptosis, upregulated caspase-3 protein expression, and downregulated bcl-xl protein expression in the myocardium of epileptic rats. Conclusions: These results indicate that myocardial cell apoptosis may contribute to myocardial injury in epilepsy. EPO protects myocardial cells from apoptosis via the JAK2/STAT5 pathway in rats with experimental epilepsy, whereas CEPO exerts antiapoptotic activity perhaps via a pathway independent of JAK2/STAT5 signaling.http://www.sciencedirect.com/science/article/pii/S0011393X15000090apoptosisepilepsyerythropoietinJAK2STAT5
spellingShingle Bao-Xin Ma, MD
Jie Li, MD
Hua Li, MD
Sui-Sheng Wu, MD
Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy
Current Therapeutic Research
apoptosis
epilepsy
erythropoietin
JAK2
STAT5
title Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy
title_full Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy
title_fullStr Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy
title_full_unstemmed Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy
title_short Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy
title_sort recombinant human erythropoietin protects myocardial cells from apoptosis via the janus activated kinase 2 signal transducer and activator of transcription 5 pathway in rats with epilepsy
topic apoptosis
epilepsy
erythropoietin
JAK2
STAT5
url http://www.sciencedirect.com/science/article/pii/S0011393X15000090
work_keys_str_mv AT baoxinmamd recombinanthumanerythropoietinprotectsmyocardialcellsfromapoptosisviathejanusactivatedkinase2signaltransducerandactivatoroftranscription5pathwayinratswithepilepsy
AT jielimd recombinanthumanerythropoietinprotectsmyocardialcellsfromapoptosisviathejanusactivatedkinase2signaltransducerandactivatoroftranscription5pathwayinratswithepilepsy
AT hualimd recombinanthumanerythropoietinprotectsmyocardialcellsfromapoptosisviathejanusactivatedkinase2signaltransducerandactivatoroftranscription5pathwayinratswithepilepsy
AT suishengwumd recombinanthumanerythropoietinprotectsmyocardialcellsfromapoptosisviathejanusactivatedkinase2signaltransducerandactivatoroftranscription5pathwayinratswithepilepsy